A Study of the Safety and Tolerability of GTX-102 in Children With Angelman Syndrome

NCT04259281 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
74
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Ultragenyx Pharmaceutical Inc